Cytarabine Injection Manufacturer & Exporter in India | Oncology Contract Manufacturing

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP is a trusted Cytarabine Injection Manufacturer in India producing advanced chemotherapy formulations for hematological malignancies and specialized oncology treatment programs.

Cytarabine Injection is widely prescribed for Acute Myeloid Leukemia Treatment and other hematological cancers. The formulation contains Cytarabine, an antimetabolite chemotherapy agent that interferes with DNA synthesis in rapidly dividing cancer cells, helping inhibit leukemia cell growth and proliferation.

The company also supplies these formulations as an Oncology Injectable Supplier and Leukemia Treatment Injection Exporter for oncology hospitals, hematology centers, institutional procurement programs, and regulated international pharmaceutical markets.

Cytarabine Injection is formulated for hematological cancer and chemotherapy treatment.

Contains Cytarabine as active ingredient
Antimetabolite chemotherapy injectable formulation
Designed for leukemia treatment protocols
Inhibits DNA synthesis in cancer cells

Cytarabine Injection is commonly used in the treatment of:

Acute Myeloid Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Chronic Myelogenous Leukemia (CML) – blast crisis phase
Non-Hodgkin’s Lymphoma (in specific regimens)
Other hematological malignancies as per clinical protocols

This chemotherapy injection is administered under strict medical supervision in oncology and hematology settings

Cytarabine Injection delivers effective chemotherapy support for leukemia treatment.

Helps inhibit leukemia cell proliferation
Supports hematological cancer management
Useful in acute leukemia treatment protocols
Effective antimetabolite mechanism of action